DNA

Genetic research

Axitinib's Mechanism of Action in Metastatic Renal Cell Carcinoma Revealed

Scientists at Istanbul Technical University have conducted a comprehensive study on the interactions between Axitinib, a second-generation tyrosine kinase inhibitor, and DNA. Their research aimed to shed light on the pharmacodynamic properties of Axitinib and explore the possibility of developing more effective DNA-binding therapeutics. Through various analytical techniques, including UV-Vis